170 related articles for article (PubMed ID: 33291367)
21. Nanoscaled hydrated antimony (V) oxide as a new approach to first-line antileishmanial drugs.
Franco AM; Grafova I; Soares FV; Gentile G; Wyrepkowski CD; Bolson MA; Sargentini É; Carfagna C; Leskelä M; Grafov A
Int J Nanomedicine; 2016; 11():6771-6780. PubMed ID: 28008252
[TBL] [Abstract][Full Text] [Related]
22. Nanoparticles Loaded with a New Thiourea Derivative: Development and
Meireles PW; de Souza DPB; Rezende MG; Borsodi MPG; de Oliveira DE; da Silva LCRP; de Souza AMT; Viana GM; Rodrigues CR; do Carmo FA; de Sousa VP; Rossi-Bergmann B; Cabral LM
Curr Drug Deliv; 2020; 17(8):694-702. PubMed ID: 32621717
[TBL] [Abstract][Full Text] [Related]
23. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
[TBL] [Abstract][Full Text] [Related]
24. Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase: chemical library screen and antileishmanial activity.
Grant KM; Dunion MH; Yardley V; Skaltsounis AL; Marko D; Eisenbrand G; Croft SL; Meijer L; Mottram JC
Antimicrob Agents Chemother; 2004 Aug; 48(8):3033-42. PubMed ID: 15273118
[TBL] [Abstract][Full Text] [Related]
25. In vitro activities of ER-119884 and E5700, two potent squalene synthase inhibitors, against Leishmania amazonensis: antiproliferative, biochemical, and ultrastructural effects.
Fernandes Rodrigues JC; Concepcion JL; Rodrigues C; Caldera A; Urbina JA; de Souza W
Antimicrob Agents Chemother; 2008 Nov; 52(11):4098-114. PubMed ID: 18765694
[TBL] [Abstract][Full Text] [Related]
26. In vitro Assessment of Camphor Hydrazone Derivatives as an Agent Against Leishmania amazonensis.
da Silva ET; de Andrade GF; Araújo ADS; Almeida ADC; Coimbra ES; de Souza MVN
Acta Parasitol; 2020 Mar; 65(1):203-207. PubMed ID: 31832921
[TBL] [Abstract][Full Text] [Related]
27. Stable assemblies of cationic bilayer fragments and CpG oligonucleotide with enhanced immunoadjuvant activity in vivo.
Rozenfeld JH; Silva SR; Ranéia PA; Faquim-Mauro E; Carmona-Ribeiro AM
J Control Release; 2012 Jun; 160(2):367-73. PubMed ID: 22036878
[TBL] [Abstract][Full Text] [Related]
28. Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro.
Freitas EO; Nico D; Guan R; Meyer-Fernandes JR; Clinch K; Evans GB; Tyler PC; Schramm VL; Palatnik-de-Sousa CB
PLoS One; 2015; 10(4):e0124183. PubMed ID: 25909893
[TBL] [Abstract][Full Text] [Related]
29. Epoxy-α-lapachone has in vitro and in vivo anti-leishmania (Leishmania) amazonensis effects and inhibits serine proteinase activity in this parasite.
Souza-Silva F; Bourguignon SC; Pereira BA; Côrtes LM; de Oliveira LF; Henriques-Pons A; Finkelstein LC; Ferreira VF; Carneiro PF; de Pinho RT; Caffarena ER; Alves CR
Antimicrob Agents Chemother; 2015 Apr; 59(4):1910-8. PubMed ID: 25583728
[TBL] [Abstract][Full Text] [Related]
30. Antileishmanial activity and cytotoxicity of Brazilian plants.
Ribeiro TG; Chávez-Fumagalli MA; Valadares DG; Franca JR; Lage PS; Duarte MC; Andrade PH; Martins VT; Costa LE; Arruda AL; Faraco AA; Coelho EA; Castilho RO
Exp Parasitol; 2014 Aug; 143():60-8. PubMed ID: 24846006
[TBL] [Abstract][Full Text] [Related]
31. Aryl thiosemicarbazones: In vitro and immunomodulatory activities against L. amazonensis.
da Silva AC; Dos Santos TAR; da Silva IVB; de Oliveira MVG; Moreira DRM; Leite ACL; Pereira VRA
Exp Parasitol; 2017 Jun; 177():57-65. PubMed ID: 28433563
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
[TBL] [Abstract][Full Text] [Related]
33. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
[TBL] [Abstract][Full Text] [Related]
34. Imipramine alters the sterol profile in Leishmania amazonensis and increases its sensitivity to miconazole.
Andrade-Neto VV; Pereira TM; Canto-Cavalheiro Md; Torres-Santos EC
Parasit Vectors; 2016 Mar; 9():183. PubMed ID: 27036654
[TBL] [Abstract][Full Text] [Related]
35. Novel functionalized 1,2,3-triazole derivatives exhibit antileishmanial activity, increase in total and mitochondrial-ROS and depolarization of mitochondrial membrane potential of Leishmania amazonensis.
Meinel RS; Almeida ADC; Stroppa PHF; Glanzmann N; Coimbra ES; da Silva AD
Chem Biol Interact; 2020 Jan; 315():108850. PubMed ID: 31634447
[TBL] [Abstract][Full Text] [Related]
36. Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity.
Casa DM; Scariot DB; Khalil NM; Nakamura CV; Mainardes RM
Exp Parasitol; 2018 Sep; 192():12-18. PubMed ID: 30026113
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
[TBL] [Abstract][Full Text] [Related]
38. Grandiflorenic acid promotes death of promastigotes via apoptosis-like mechanism and affects amastigotes by increasing total iron bound capacity.
Bortoleti BTDS; Gonçalves MD; Tomiotto-Pellissier F; Miranda-Sapla MM; Assolini JP; Carloto ACM; de Carvalho PGC; Cardoso ILA; Simão ANC; Arakawa NS; Costa IN; Conchon-Costa I; Pavanelli WR
Phytomedicine; 2018 Jul; 46():11-20. PubMed ID: 30097110
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis.
de Macedo-Silva ST; Urbina JA; de Souza W; Rodrigues JC
PLoS One; 2013; 8(12):e83247. PubMed ID: 24376670
[TBL] [Abstract][Full Text] [Related]
40. Chemical Characterization, Antileishmanial Activity, and Cytotoxicity Effects of the Essential Oil from Leaves of Pluchea carolinensis (Jacq.) G. Don. (Asteraceae).
García M; Scull R; Satyal P; Setzer WN; Monzote L
Phytother Res; 2017 Sep; 31(9):1419-1426. PubMed ID: 28703380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
